427
Participants
Start Date
April 7, 2016
Primary Completion Date
April 3, 2018
Study Completion Date
April 3, 2018
Adalimumab
Pre-filled syringe or pen, administered by subcutaneous injection
AbbVie Care 2.0
Supportive services provided to participants included reminder calls, emails, text messages, nursing services, dietician, and psychological support. An adalimumab starter pack, injection guide, digital and print educational materials were also provided.
Lead Sponsor
AbbVie
INDUSTRY